HU9300388D0 - New medical preparatives with 5-(1-hydroxi-2-chlorine-ethyl)-4-methyl-triazole content and method for preparing them - Google Patents

New medical preparatives with 5-(1-hydroxi-2-chlorine-ethyl)-4-methyl-triazole content and method for preparing them

Info

Publication number
HU9300388D0
HU9300388D0 HU93388A HU38893A HU9300388D0 HU 9300388 D0 HU9300388 D0 HU 9300388D0 HU 93388 A HU93388 A HU 93388A HU 38893 A HU38893 A HU 38893A HU 9300388 D0 HU9300388 D0 HU 9300388D0
Authority
HU
Hungary
Prior art keywords
hydroxi
chlorine
ethyl
methyl
preparing
Prior art date
Application number
HU93388A
Other languages
Hungarian (hu)
Other versions
HUT65821A (en
Inventor
Bernard Robin Boar
Alan John Cross
Alfred Richard Green
Curt-Eric Hagberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of HU9300388D0 publication Critical patent/HU9300388D0/en
Publication of HUT65821A publication Critical patent/HUT65821A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

New pharmaceutical formulations comprising 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole or optical isomers or a pharmaceutically acceptable salt or solvate thereof.
HU9300388A 1990-08-15 1991-08-07 Process for preparing anti-neurodegenerative pharmaceutical preparations containing 5-(chloro-1-hydroxyethyl)-4-methylthiazole HUT65821A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002659A SE9002659D0 (en) 1990-08-15 1990-08-15 NEW PHARMACEUTICAL FORMULATIONS

Publications (2)

Publication Number Publication Date
HU9300388D0 true HU9300388D0 (en) 1993-04-28
HUT65821A HUT65821A (en) 1994-07-28

Family

ID=20380161

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9300388A HUT65821A (en) 1990-08-15 1991-08-07 Process for preparing anti-neurodegenerative pharmaceutical preparations containing 5-(chloro-1-hydroxyethyl)-4-methylthiazole

Country Status (26)

Country Link
US (1) US5385921A (en)
EP (1) EP0619734B1 (en)
JP (1) JP3094077B2 (en)
AT (1) ATE164066T1 (en)
AU (1) AU657490B2 (en)
BG (1) BG97446A (en)
CA (1) CA2088775A1 (en)
CZ (1) CZ279586B6 (en)
DE (1) DE69129126T2 (en)
DK (1) DK0619734T3 (en)
ES (1) ES2114891T3 (en)
FI (1) FI930608A0 (en)
HU (1) HUT65821A (en)
IE (1) IE912818A1 (en)
IL (1) IL99169A (en)
IS (1) IS3743A7 (en)
LT (1) LT3978B (en)
LV (1) LV10921B (en)
NO (1) NO303447B1 (en)
NZ (1) NZ239329A (en)
PT (1) PT98688B (en)
RO (1) RO112994B1 (en)
RU (1) RU2093155C1 (en)
SE (1) SE9002659D0 (en)
SK (1) SK8793A3 (en)
WO (1) WO1992003134A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901658D0 (en) * 1999-05-06 1999-05-06 Astra Ab New formulation
SE9904177D0 (en) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
WO2002083863A2 (en) 2001-04-17 2002-10-24 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
CN103772313B (en) * 2014-01-02 2015-10-14 郑桂富 A kind of synthetic method of 4-methyl-5-(2-hydroxyethyl) thiazole
CN112262814A (en) * 2020-10-26 2021-01-26 宜宾学院 Chicken raising method by cinnamomum longepaniculatum leaf residue fermentation bed

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2825966A1 (en) * 1978-06-14 1980-01-03 Basf Ag ACID GALVANIC NICKEL BATH, WHICH CONTAINS SULFOBETAINE AS A GLOSSY AND LEVELING AGENT
GB8600783D0 (en) * 1986-01-14 1986-02-19 Merck Sharp & Dohme N-methyl-d-aspartate receptor antagonists

Also Published As

Publication number Publication date
HUT65821A (en) 1994-07-28
EP0619734B1 (en) 1998-03-18
US5385921A (en) 1995-01-31
CZ16693A3 (en) 1994-02-16
FI930608A (en) 1993-02-11
WO1992003134A1 (en) 1992-03-05
IL99169A (en) 1995-10-31
NO930452L (en) 1993-02-09
IE912818A1 (en) 1992-02-26
IS3743A7 (en) 1992-02-16
CZ279586B6 (en) 1995-05-17
SE9002659D0 (en) 1990-08-15
SK8793A3 (en) 1993-07-07
LT3978B (en) 1996-06-25
PT98688A (en) 1992-07-31
AU8409291A (en) 1992-03-17
LTIP1714A (en) 1995-09-25
NO303447B1 (en) 1998-07-13
JP3094077B2 (en) 2000-10-03
DE69129126D1 (en) 1998-04-23
NO930452D0 (en) 1993-02-09
FI930608A0 (en) 1993-02-11
AU657490B2 (en) 1995-03-16
NZ239329A (en) 1994-11-25
ES2114891T3 (en) 1998-06-16
LV10921B (en) 1996-08-20
DE69129126T2 (en) 1998-07-23
RO112994B1 (en) 1998-03-30
JPH06500097A (en) 1994-01-06
PT98688B (en) 1999-01-29
EP0619734A1 (en) 1994-10-19
CA2088775A1 (en) 1992-02-16
ATE164066T1 (en) 1998-04-15
RU2093155C1 (en) 1997-10-20
DK0619734T3 (en) 1998-10-05
IL99169A0 (en) 1992-07-15
LV10921A (en) 1995-12-20
BG97446A (en) 1994-03-24

Similar Documents

Publication Publication Date Title
HU912266D0 (en) Process for the production of solid medical preparations with controlled portioning of the active agents for oral use
NZ244880A (en) 2-(n-morpholino or n-alkylpiperazino)-4-amino-5-phenyl-pyrimidine derivatives; medicaments
AU650484B2 (en) Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof
IL99393A0 (en) Thiazolidine derivatives,methods for the preparation thereof and pharmaceutical composition containing the same
HU912013D0 (en) Process for the production of benzopyrane derivatives and their heterocyclic analogues, antiyschemic medical preparations
AU2437388A (en) 2, 3-Dihydro-2, 2-dimethyl-3-hydroxy-6-(trifluoroalkoxy)-4- amino derivatives
GB2191695B (en) An ophthalmic pharmaceutical composition for cataract
AU7257891A (en) New benzimidazole derivatives, method for preparing them and their pharmaceutical use
HU9300388D0 (en) New medical preparatives with 5-(1-hydroxi-2-chlorine-ethyl)-4-methyl-triazole content and method for preparing them
AU1888488A (en) Substituted benzimidazoles, a process for the preparation thereof, pharmaceutical formulations containing them, and theuse thereof
AU8225391A (en) The use of inositolmonophosphate for the preparing of a medicament effective as a neuropeptide gamma-antagonist
AU4218789A (en) Process for disinfecting medical casting materials
IT8722276A0 (en) SOLUBLES SUITABLE FOR MARTIAL THERAPY POLYPEPTIDE DERIVATIVES WITH HIGH PREPARATION PROCEDURES AND IRON CONTENT AND HIGHLY THEIR PHARMACEUTICAL FORMS.
LTIP1735A (en) Use of bambuterol for the manufacture of a pharmaceutical preparation with lipid lowering effect
NZ239186A (en) Substituted 2-(9-fluorenonyl)-carbapenem derivatives and pharmaceutical
NO891231D0 (en) CEPHALOSPORIN DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF.
AU8199591A (en) Drug for reducing intraocular pressure
NO903136L (en) CEPHALOSPORIN DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF.
AU8760691A (en) Drug therapy for alcohol abusers
DK555288D0 (en) CEPHALOSPORIN DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF, PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES AND INTERMEDIATES FOR USING THE PROCEDURE
JO1692B1 (en) New use of apharmaceutleally accepted salt preparation
AU3127289A (en) Apparatus for intraocular drug delivery
HU908316D0 (en) Process for the production of medical preparations containing new amino-acid derivatives with medicative effect
AU3127389A (en) Apparatus for intraocular drug dialysis
AU7753491A (en) Single-use syringe

Legal Events

Date Code Title Description
DFA9 Temporary protection cancelled due to abandonment